Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT
NCT02419781 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2018-02-27
Summary
The aim of this study is to clarify the efficacy of the endovascular treatment for acute ischemic stroke patients with large vessel occlusion and are not respond to intravenous recombinant tissue plasminogen activator (rt-PA) therapy.
Conditions
Interventions
- PROCEDURE
-
Rescue endovascular therapy
endovascular treatment using any devises for acute ischemic stroke patients with large vessel occlusion and not respond to intravenous recombinant tissue plasminogen activator (rt-PA) therapy
- PROCEDURE
-
No endovascular therapy
Sponsors & Collaborators
-
Shinichi Yoshimura
lead OTHER
Principal Investigators
-
Shinichi Yoshimura, MD, PhD · Hyogo Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-07-31
Countries
- Japan
Study Locations
More Related Trials
-
Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions
NCT04170647 ·Status: UNKNOWN
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
NCT04879615 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion
NCT07335107 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke
NCT00147316 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
NCT05856851 ·Status: RECRUITING ·Phase: PHASE3
-
Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital
NCT04177615 ·Status: UNKNOWN ·Phase: NA
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)
NCT06131385 ·Status: RECRUITING
-
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
NCT02002325 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT01104467 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke
NCT01869478 ·Status: TERMINATED ·Phase: PHASE2
-
Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy
NCT03198715 ·Status: COMPLETED ·Phase: NA
-
OUTCOME AND SAFETY OF RECANALIZATION TREATMENTS IN ISCHEMIC STROKE DUE TO ACUTE BASILAR ARTERY OCCLUSION
NCT05402878 ·Status: UNKNOWN
-
Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial
NCT03044184 ·Status: UNKNOWN ·Phase: PHASE3
-
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
NCT07279259 ·Status: RECRUITING ·Phase: PHASE2
-
Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice
NCT06018181 ·Status: COMPLETED
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920 ·Status: COMPLETED ·Phase: PHASE3
-
Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)
NCT00968929 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
NCT02907736 ·Status: WITHDRAWN
-
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NCT04674293 ·Status: UNKNOWN
-
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-A )
NCT06492239 ·Status: COMPLETED ·Phase: PHASE2
-
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )
NCT06492265 ·Status: RECRUITING ·Phase: PHASE2
-
MLC1501 Study Assessing Efficacy in STROke Recovery
NCT05046106 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3